MB, Levis & Associates’s iShares iBonds Dec 2029 Term Corporate ETF IBDU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-533,909
Closed -$12.1M 293
2024
Q2
$12.1M Buy
533,909
+12,868
+2% +$290K 6.36% 7
2024
Q1
$11.9M Buy
521,041
+12,656
+2% +$289K 6.38% 7
2023
Q4
$11.7M Buy
508,385
+22,239
+5% +$493K 6.71% 7
2023
Q3
$10.6M Buy
486,146
+7,389
+2% +$164K 6.9% 5
2023
Q2
$10.7M Buy
478,757
+75,270
+19% +$1.71M 6.89% 7
2023
Q1
$9.23M Buy
403,487
+38,048
+10% +$860K 6.42% 7
2022
Q4
$8.1M Buy
+365,439
New +$8.05M 6.34% 6

Other funds holding IBDU

MB, Levis & Associates's IBDU Position: Q3 2024 in Review

MB, Levis & Associates sold out of iShares iBonds Dec 2029 Term Corporate ETF (IBDU) in Q3 2024, closing a stake of 533,909 shares — an estimated $12.1M sold.

MB, Levis & Associates first reported a position in IBDU in Q4 2022 and held it in 7 quarters. The position peaked at $12.1M in Q2 2024. 225 funds tracked by Wall St. Rank hold IBDU as of Q3 2024.

  • MB, Levis & Associates reported no remaining iShares iBonds Dec 2029 Term Corporate ETF position as of Q3 2024 after selling out during the quarter.
  • MB, Levis & Associates sold 533,909 iShares iBonds Dec 2029 Term Corporate ETF shares in Q3 2024, an estimated $12.1M.
  • MB, Levis & Associates first reported a position in iShares iBonds Dec 2029 Term Corporate ETF in Q4 2022 and held it in 7 quarters.
  • MB, Levis & Associates's iShares iBonds Dec 2029 Term Corporate ETF position peaked at $12.1M in Q2 2024.
  • 225 funds tracked by Wall St. Rank held iShares iBonds Dec 2029 Term Corporate ETF as of Q3 2024.

Based on MB, Levis & Associates's 13F filing for Q3 2024, filed 7 May 2025.